Cargando…
NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients
AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859222/ https://www.ncbi.nlm.nih.gov/pubmed/29568200 http://dx.doi.org/10.3748/wjg.v24.i11.1196 |
_version_ | 1783307778065956864 |
---|---|
author | Schäffler, Holger Rohde, Maria Rohde, Sarah Huth, Astrid Gittel, Nicole Hollborn, Hannes Koczan, Dirk Glass, Änne Lamprecht, Georg Jaster, Robert |
author_facet | Schäffler, Holger Rohde, Maria Rohde, Sarah Huth, Astrid Gittel, Nicole Hollborn, Hannes Koczan, Dirk Glass, Änne Lamprecht, Georg Jaster, Robert |
author_sort | Schäffler, Holger |
collection | PubMed |
description | AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were genotyped regarding nucleotide-binding oligomerization domain 2 (NOD2), and PBMCs from wild-type (WT)-NOD2 patients, patients with homozygous or heterozygous NOD2 mutations and healthy donors were isolated for further analysis. The cells were cultured with vitamin D, peptidoglycan (PGN) and lipopolysaccharide (LPS) for defined periods of time before RNA was isolated and subjected to microarray analysis using Clariom S assays and quantitative real-time PCR. NOD2- and disease-specific gene expression profiles were evaluated with repeated measure ANOVA by a general linear model. RESULTS: Employing microarray assays, a total of 267 genes were identified that were significantly up- or downregulated in PBMCs of WT-NOD2 patients, compared to healthy donors after challenge with vitamin D and/or a combination of LPS and PGN (P < 0.05; threshold: ≥ 2-fold change). For further analysis by real-time PCR, genes with known impact on inflammation and immunity were selected that fulfilled predefined expression criteria. In a larger cohort of patients and controls, a disease-associated expression pattern, with higher transcript levels in vitamin D-treated PBMCs from patients, was observed for three of these genes, CLEC5A (P < 0.030), lysozyme (LYZ; P < 0.047) and TREM1 (P < 0.023). Six genes were found to be expressed in a NOD2-dependent manner (CD101, P < 0.002; CLEC5A, P < 0.020; CXCL5, P < 0.009; IL-24, P < 0.044; ITGB2, P < 0.041; LYZ, P < 0.042). Interestingly, the highest transcript levels were observed in patients with heterozygous NOD2 mutations. CONCLUSION: Our data identify CLEC5A and LYZ as CD- and NOD2-associated genes of PBMCs and encourage further studies on their pathomechanistic roles. |
format | Online Article Text |
id | pubmed-5859222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-58592222018-03-22 NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients Schäffler, Holger Rohde, Maria Rohde, Sarah Huth, Astrid Gittel, Nicole Hollborn, Hannes Koczan, Dirk Glass, Änne Lamprecht, Georg Jaster, Robert World J Gastroenterol Basic Study AIM: To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn’s disease (CD) patients in clinical remission. METHODS: Patients with CD in clinical remission or with very low disease activity according to the Crohn’s disease activity index were genotyped regarding nucleotide-binding oligomerization domain 2 (NOD2), and PBMCs from wild-type (WT)-NOD2 patients, patients with homozygous or heterozygous NOD2 mutations and healthy donors were isolated for further analysis. The cells were cultured with vitamin D, peptidoglycan (PGN) and lipopolysaccharide (LPS) for defined periods of time before RNA was isolated and subjected to microarray analysis using Clariom S assays and quantitative real-time PCR. NOD2- and disease-specific gene expression profiles were evaluated with repeated measure ANOVA by a general linear model. RESULTS: Employing microarray assays, a total of 267 genes were identified that were significantly up- or downregulated in PBMCs of WT-NOD2 patients, compared to healthy donors after challenge with vitamin D and/or a combination of LPS and PGN (P < 0.05; threshold: ≥ 2-fold change). For further analysis by real-time PCR, genes with known impact on inflammation and immunity were selected that fulfilled predefined expression criteria. In a larger cohort of patients and controls, a disease-associated expression pattern, with higher transcript levels in vitamin D-treated PBMCs from patients, was observed for three of these genes, CLEC5A (P < 0.030), lysozyme (LYZ; P < 0.047) and TREM1 (P < 0.023). Six genes were found to be expressed in a NOD2-dependent manner (CD101, P < 0.002; CLEC5A, P < 0.020; CXCL5, P < 0.009; IL-24, P < 0.044; ITGB2, P < 0.041; LYZ, P < 0.042). Interestingly, the highest transcript levels were observed in patients with heterozygous NOD2 mutations. CONCLUSION: Our data identify CLEC5A and LYZ as CD- and NOD2-associated genes of PBMCs and encourage further studies on their pathomechanistic roles. Baishideng Publishing Group Inc 2018-03-21 2018-03-21 /pmc/articles/PMC5859222/ /pubmed/29568200 http://dx.doi.org/10.3748/wjg.v24.i11.1196 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Basic Study Schäffler, Holger Rohde, Maria Rohde, Sarah Huth, Astrid Gittel, Nicole Hollborn, Hannes Koczan, Dirk Glass, Änne Lamprecht, Georg Jaster, Robert NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title | NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title_full | NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title_fullStr | NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title_full_unstemmed | NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title_short | NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients |
title_sort | nod2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from crohn’s disease patients |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859222/ https://www.ncbi.nlm.nih.gov/pubmed/29568200 http://dx.doi.org/10.3748/wjg.v24.i11.1196 |
work_keys_str_mv | AT schafflerholger nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT rohdemaria nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT rohdesarah nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT huthastrid nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT gittelnicole nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT hollbornhannes nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT koczandirk nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT glassanne nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT lamprechtgeorg nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients AT jasterrobert nod2anddiseasespecificgeneexpressionprofilesofperipheralbloodmononuclearcellsfromcrohnsdiseasepatients |